124 related articles for article (PubMed ID: 37414254)
1. Cancer immunotherapy response prediction from multi-modal clinical and image data using semi-supervised deep learning.
Wang X; Jiang Y; Chen H; Zhang T; Han Z; Chen C; Yuan Q; Xiong W; Wang W; Li G; Heng PA; Li R
Radiother Oncol; 2023 Sep; 186():109793. PubMed ID: 37414254
[TBL] [Abstract][Full Text] [Related]
2. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
3. Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images.
Tian P; He B; Mu W; Liu K; Liu L; Zeng H; Liu Y; Jiang L; Zhou P; Huang Z; Dong D; Li W
Theranostics; 2021; 11(5):2098-2107. PubMed ID: 33500713
[No Abstract] [Full Text] [Related]
4. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics.
Jiang Y; Zhou K; Sun Z; Wang H; Xie J; Zhang T; Sang S; Islam MT; Wang JY; Chen C; Yuan Q; Xi S; Li T; Xu Y; Xiong W; Wang W; Li G; Li R
Cell Rep Med; 2023 Aug; 4(8):101146. PubMed ID: 37557177
[TBL] [Abstract][Full Text] [Related]
6. Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients.
Farina B; Guerra ADR; Bermejo-Peláez D; Miras CP; Peral AA; Madueño GG; Jaime JC; Vilalta-Lacarra A; Pérez JR; Muñoz-Barrutia A; Peces-Barba GR; Maceiras LS; Gil-Bazo I; Gómez MD; Ledesma-Carbayo MJ
J Transl Med; 2023 Mar; 21(1):174. PubMed ID: 36872371
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images.
Mu W; Jiang L; Shi Y; Tunali I; Gray JE; Katsoulakis E; Tian J; Gillies RJ; Schabath MB
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34135101
[TBL] [Abstract][Full Text] [Related]
8. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
[TBL] [Abstract][Full Text] [Related]
9. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
10. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.
Jiang Y; Zhang Z; Yuan Q; Wang W; Wang H; Li T; Huang W; Xie J; Chen C; Sun Z; Yu J; Xu Y; Poultsides GA; Xing L; Zhou Z; Li G; Li R
Lancet Digit Health; 2022 May; 4(5):e340-e350. PubMed ID: 35461691
[TBL] [Abstract][Full Text] [Related]
11. Dual-energy CT-based deep learning radiomics can improve lymph node metastasis risk prediction for gastric cancer.
Li J; Dong D; Fang M; Wang R; Tian J; Li H; Gao J
Eur Radiol; 2020 Apr; 30(4):2324-2333. PubMed ID: 31953668
[TBL] [Abstract][Full Text] [Related]
12. Non-Invasive Measurement Using Deep Learning Algorithm Based on Multi-Source Features Fusion to Predict PD-L1 Expression and Survival in NSCLC.
Wang C; Ma J; Shao J; Zhang S; Li J; Yan J; Zhao Z; Bai C; Yu Y; Li W
Front Immunol; 2022; 13():828560. PubMed ID: 35464416
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a deep learning signature for predicting lymph node metastasis in lung adenocarcinoma: comparison with radiomics signature and clinical-semantic model.
Ma X; Xia L; Chen J; Wan W; Zhou W
Eur Radiol; 2023 Mar; 33(3):1949-1962. PubMed ID: 36169691
[TBL] [Abstract][Full Text] [Related]
14. A multi-omics-based serial deep learning approach to predict clinical outcomes of single-agent anti-PD-1/PD-L1 immunotherapy in advanced stage non-small-cell lung cancer.
Yang Y; Yang J; Shen L; Chen J; Xia L; Ni B; Ge L; Wang Y; Lu S
Am J Transl Res; 2021; 13(2):743-756. PubMed ID: 33594323
[TBL] [Abstract][Full Text] [Related]
15. Deep learning radio-clinical signatures for predicting neoadjuvant chemotherapy response and prognosis from pretreatment CT images of locally advanced gastric cancer patients.
Hu C; Chen W; Li F; Zhang Y; Yu P; Yang L; Huang L; Sun J; Chen S; Shi C; Sun Y; Ye Z; Yuan L; Chen J; Wei Q; Xu J; Xu H; Tong Y; Bao Z; Huang C; Li Y; Du Y; Xu Z; Cheng X
Int J Surg; 2023 Jul; 109(7):1980-1992. PubMed ID: 37132183
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Radiological Features and Deep Learning for the Non-Invasive Evaluation of Programmed Death Ligand 1 Expression Levels in Gastric Cancer Patients: A Digital Biopsy Study.
Xie W; Jiang Z; Zhou X; Zhang X; Zhang M; Liu R; Zheng L; Xin F; Lu Y; Wang D
Acad Radiol; 2023 Jul; 30(7):1317-1328. PubMed ID: 36369191
[TBL] [Abstract][Full Text] [Related]
17. Predicting muscle invasion in bladder cancer based on MRI: A comparison of radiomics, and single-task and multi-task deep learning.
Li J; Qiu Z; Cao K; Deng L; Zhang W; Xie C; Yang S; Yue P; Zhong J; Lyu J; Huang X; Zhang K; Zou Y; Huang B
Comput Methods Programs Biomed; 2023 May; 233():107466. PubMed ID: 36907040
[TBL] [Abstract][Full Text] [Related]
18. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
19. Deep Learning-Based Stratification of Gastric Cancer Patients from Hematoxylin and Eosin-Stained Whole Slide Images by Predicting Molecular Features for Immunotherapy Response.
Wei Z; Zhao X; Chen J; Sun Q; Wang Z; Wang Y; Ye Z; Yuan Y; Sun L; Jing J
Am J Pathol; 2023 Oct; 193(10):1517-1527. PubMed ID: 37356573
[TBL] [Abstract][Full Text] [Related]
20. Deep learning predicts resistance to neoadjuvant chemotherapy for locally advanced gastric cancer: a multicenter study.
Zhang J; Cui Y; Wei K; Li Z; Li D; Song R; Ren J; Gao X; Yang X
Gastric Cancer; 2022 Nov; 25(6):1050-1059. PubMed ID: 35932353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
